Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Vardenafil | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Vardenafil | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Vardenafil | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Vardenafil | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Vardenafil | hsa00190 | Oxidative phosphorylation | 5.76E-06 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Vardenafil | hsa00220 | Arginine biosynthesis | 1.43E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Vardenafil | hsa00500 | Starch and sucrose metabolism | 1.91E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Vardenafil | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.11E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Vardenafil | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Vardenafil | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Vardenafil | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Vardenafil | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 8.72E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Vardenafil | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Vardenafil | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.34E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Vardenafil | hsa00670 | One carbon pool by folate | 1.14E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Vardenafil | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Vardenafil | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Vardenafil | hsa00860 | Porphyrin and chlorophyll metabolism | 3.15E-04 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Vardenafil | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Vardenafil | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Vardenafil | hsa01040 | Biosynthesis of unsaturated fatty acids | 4.28E-02 | 1 | P22307 | SCP2 | More | | Vardenafil | hsa01100 | Metabolic pathways | 5.54E-03 | 37 | Q9NR34, P05089, Q99707, P11310, P27707, P32320, Q13956, P22748, P55809, P06280, Q16875, O43286, O43451, P30043, P05186, P24666, O14772, O95954, Q9HCC0, P33121, Q02318, P57054, Q9UNP4, O15466, P36551, Q9BX95, P32321, Q9P2R7, Q9BPW9, O75911, Q9UHY7, P43490, Q9Y2B2, P46976, P35573, P06737, Q16718 | MAN1C1, ARG1, MTR, ACADM, DCK, CDA, PDE6H, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, BLVRB, ALPL, ACP1, FPGT, FTCD, MCCC2, ACSL1, CYP27A1, PIGP, ST3GAL5, ST8SIA5, CPOX, SGPP1, DCTD, SUCLA2, DHRS9, DHRS3, ENOPH1, PBEF1, PIGL, GYG1, AGL, PYGL, NDUFA5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | Q99707 | MTR | Methionine synthase | 0.869 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | P11310 | ACADM | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 0.736 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | P27707 | DCK | Deoxycytidine kinase | 0.723 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | P30043 | BLVRB | Flavin reductase | -0.864 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | O14772 | FPGT | Fucose-1-phosphate guanylyltransferase | 0.742 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | O95954 | FTCD | Formimidoyltransferase-cyclodeaminase | -0.774 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | Q02318 | CYP27A1 | Sterol 26-hydroxylase, mitochondrial | -0.708 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | O15466 | ST8SIA5 | Alpha-2,8-sialyltransferase 8E | -0.766 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | P36551 | CPOX | Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial | 0.719 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | Q9P2R7 | SUCLA2 | Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0.722 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | Q9Y2B2 | PIGL | N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase | 0.8 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | P35573 | AGL | Glycogen debranching enzyme | 0.704 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.766 |
| Vardenafil | hsa01230 | Biosynthesis of amino acids | 3.27E-03 | 5 | P51854, P60891, Q99707, P50213, P37837 | TKTL1, PRPS1, MTR, IDH3A, TALDO1 | More | | Vardenafil | hsa01524 | Platinum drug resistance | 2.24E-03 | 4 | O15392, P78417, P11388, P52701 | BIRC5, GSTO1, TOP2A, MSH6 | More | | Vardenafil | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Vardenafil | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Vardenafil | hsa03013 | RNA transport | 1.21E-07 | 18 | O14980, P52298, O14893, P61326, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, Q14152, P55884, O15371, O75822, P78345, P20042, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, GEMIN2, MAGOH, RNPS1, NXF1, NUP54, NUP214, UBE2I, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, EIF4A2, EIF4B, TACC3 | More | | Vardenafil | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Vardenafil | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Vardenafil | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Vardenafil | hsa03040 | Spliceosome | 2.91E-04 | 14 | Q14562, O43143, O60508, P08579, Q15427, O75940, P38159, P61978, O75494, Q07955, Q01130, Q13243, P11142, O43447 | DHX8, DHX15, CDC40, SNRPB2, SF3B4, SMNDC1, RBMX, HNRPK, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, PPIH | More | | Vardenafil | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | | Vardenafil | hsa03060 | Protein export | 1.20E-03 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Vardenafil | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | | Vardenafil | hsa04014 | Ras signaling pathway | 1.70E-02 | 7 | P20827, Q9NRA1, P49767, P17252, P0DP23, P62873, P19174 | EFNA1, PDGFC, VEGFC, PRKCA, CALM1, GNB1, PLCG1 | More | | Vardenafil | hsa04015 | Rap1 signaling pathway | 4.58E-02 | 6 | P20827, Q9NRA1, P49767, P0DP23, P17252, P19174 | EFNA1, PDGFC, VEGFC, CALM1, PRKCA, PLCG1 | More | | Vardenafil | hsa04020 | Calcium signaling pathway | 3.88E-06 | 14 | Q96DU7, P21796, P45880, Q13557, P17252, P21860, P30679, P19174, P0DP23, P51828, P20020, P23634, Q9NRA1, P49767 | ITPKC, VDAC1, VDAC2, CAMK2D, PRKCA, ERBB3, GNA15, PLCG1, CALM1, ADCY7, ATP2B1, ATP2B4, PDGFC, VEGFC | More | | Vardenafil | hsa04022 | cGMP-PKG signaling pathway | 4.72E-02 | 4 | Q99941, P23634, P51828, P45880 | CREBL1, ATP2B4, ADCY7, VDAC2 | More | | Vardenafil | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Vardenafil | hsa04062 | Chemokine signaling pathway | 1.83E-02 | 8 | P25024, P25025, P09341, P19875, P42338, P19174, P63218, P50151 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNG5, GNG10 | More | | Vardenafil | hsa04064 | NF-kappa B signaling pathway | 1.69E-04 | 16 | O00463, P14778, P01584, P19174, Q04759, Q13077, Q16548, P06239, Q8WV28, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | TRAF5, IL1R1, IL1B, PLCG1, PRKCQ, TRAF1, BCL2A1, LCK, BLNK, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Vardenafil | hsa04070 | Phosphatidylinositol signaling system | 4.40E-02 | 4 | P19174, P0DP23, P23743, P17252 | PLCG1, CALM1, DGKA, PRKCA | More | | Vardenafil | hsa04071 | Sphingolipid signaling pathway | 1.87E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Vardenafil | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Vardenafil | hsa04114 | Oocyte meiosis | 2.05E-02 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Vardenafil | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Vardenafil | hsa04130 | SNARE interactions in vesicular transport | 1.27E-02 | 1 | O15155 | BET1 | More | | Vardenafil | hsa04136 | Autophagy - other | 2.35E-05 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Vardenafil | hsa04141 | Protein processing in endoplasmic reticulum | 3.64E-02 | 5 | Q99941, O75460, P11142, Q9H3Z4, P07900 | CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1 | More | | Vardenafil | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Vardenafil | hsa04144 | Endocytosis | 1.67E-02 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | | Vardenafil | hsa04145 | Phagosome | 4.68E-02 | 5 | Q15080, P14598, Q13509, P68371, Q13488 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1 | More | | Vardenafil | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Vardenafil | hsa04213 | Longevity regulating pathway - multiple species | 2.70E-03 | 7 | P42338, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Vardenafil | hsa04217 | Necroptosis | 1.07E-03 | 11 | P01375, P01568, P48023, P42224, Q14765, P08238, Q6FI13, Q99878, Q93077, O43633, Q08752 | TNF, IFNA21, FASLG, STAT1, STAT4, HSP90AB1, H2AC18; H2AC19, H2AC14, HIST1H2AC, CHMP2A, PPID | More | | Vardenafil | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.98E-02 | 4 | P51828, Q99941, Q13557, P23634 | ADCY7, CREBL1, CAMK2D, ATP2B4 | More | | Vardenafil | hsa04270 | Vascular smooth muscle contraction | 6.96E-03 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Vardenafil | hsa04310 | Wnt signaling pathway | 5.60E-03 | 3 | P30279, Q13485, O43318 | CCND2, SMAD4, MAP3K7 | More | | Vardenafil | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Vardenafil | hsa04360 | Axon guidance | 2.29E-02 | 5 | P16333, P20827, O95631, P17252, P19174 | NCK1, EFNA1, NTN1, PRKCA, PLCG1 | More | | Vardenafil | hsa04370 | VEGF signaling pathway | 1.29E-02 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Vardenafil | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Vardenafil | hsa04520 | Adherens junction | 3.91E-02 | 2 | Q13485, O43318 | SMAD4, MAP3K7 | More | | Vardenafil | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Vardenafil | hsa04540 | Gap junction | 1.67E-02 | 4 | P17252, Q13509, P68371, Q9NRA1 | PRKCA, TUBB3, TUBB2C, PDGFC | More | | Vardenafil | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Vardenafil | hsa04612 | Antigen processing and presentation | 8.21E-03 | 5 | P26715, P26717, Q07444, Q13241, P01732 | KLRC1, KLRC2, KLRC3, KLRD1, CD8A | More | | Vardenafil | hsa04613 | Neutrophil extracellular trap formation | 9.88E-05 | 18 | O60603, P05164, P08246, Q9UM07, P04908, Q6FI13, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Vardenafil | hsa04623 | Cytosolic DNA-sensing pathway | 8.84E-04 | 4 | P01584, P01568, P25963, Q8NHW4 | IL1B, IFNA21, NFKBIA, CCL4L2 | More | | Vardenafil | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Vardenafil | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Vardenafil | hsa04650 | Natural killer cell mediated cytotoxicity | 1.17E-06 | 11 | P19174, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, P26717, Q07444, P26715 | PLCG1, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, KLRC2, KLRC3, KLRC1 | More | | Vardenafil | hsa04657 | IL-17 signaling pathway | 3.11E-05 | 13 | P25963, P08238, O00463, Q07955, Q16539, P49841, P09341, P14780, Q9UJX4, P04141, P80188, P01375, P06702 | NFKBIA, HSP90AB1, TRAF5, SFRS1, MAPK14, GSK3B, CXCL1, MMP9, ANAPC5, CSF2, LCN2, TNF, S100A9 | More | | Vardenafil | hsa04658 | Th1 and Th2 cell differentiation | 6.40E-08 | 10 | Q04759, P07766, P20963, P09693, P19174, P06239, P23771, Q9UL17, P14784, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, GATA3, TBX21, IL2RB, RUNX3 | More | | Vardenafil | hsa04659 | Th17 cell differentiation | 1.02E-05 | 10 | Q04759, P19174, P06239, P14784, P14778, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Vardenafil | hsa04660 | T cell receptor signaling pathway | 2.28E-06 | 16 | P04141, P25963, Q04759, P42338, P10747, O95267, Q08881, P19174, P16333, P07766, P20963, P09693, P01732, Q13191, P06239, P29350 | CSF2, NFKBIA, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, PLCG1, NCK1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, PTPN6 | More | | Vardenafil | hsa04662 | B cell receptor signaling pathway | 1.49E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Vardenafil | hsa04664 | Fc epsilon RI signaling pathway | 2.20E-03 | 6 | P01375, Q16539, P42338, Q9UQC2, P07948, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, ALOX5 | More | | Vardenafil | hsa04668 | TNF signaling pathway | 2.47E-03 | 8 | P01375, O00463, Q16539, Q99941, P01584, P20749, P14780, O95429 | TNF, TRAF5, MAPK14, CREBL1, IL1B, BCL3, MMP9, BAG4 | More | | Vardenafil | hsa04713 | Circadian entrainment | 3.32E-02 | 4 | P0DP23, P17252, P62873, O15055 | CALM1, PRKCA, GNB1, PER2 | More | | Vardenafil | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Vardenafil | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Vardenafil | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Vardenafil | hsa04724 | Glutamatergic synapse | 5.94E-03 | 4 | O15399, P63218, P50151, P15104 | GRIN2D, GNG5, GNG10, GLUL | More | | Vardenafil | hsa04725 | Cholinergic synapse | 4.10E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Vardenafil | hsa04727 | GABAergic synapse | 1.63E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Vardenafil | hsa04744 | Phototransduction | 1.18E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Vardenafil | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.97E-05 | 10 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P24723, Q04759, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1 | More | | Vardenafil | hsa04911 | Insulin secretion | 1.48E-02 | 3 | P51828, Q99941, Q13557 | ADCY7, CREBL1, CAMK2D | More | | Vardenafil | hsa04914 | Progesterone-mediated oocyte maturation | 2.66E-02 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | Vardenafil | hsa04915 | Estrogen signaling pathway | 4.19E-03 | 8 | Q99941, Q08828, P51828, P07900, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ADCY1, ADCY7, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Vardenafil | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Vardenafil | hsa04925 | Aldosterone synthesis and secretion | 5.19E-03 | 4 | Q99941, P51828, Q13557, P23634 | CREBL1, ADCY7, CAMK2D, ATP2B4 | More | | Vardenafil | hsa04926 | Relaxin signaling pathway | 8.02E-04 | 6 | P42338, P63218, P50151, P49767, P30679, P49407 | PIK3CB, GNG5, GNG10, VEGFC, GNA15, ARRB1 | More | | Vardenafil | hsa04929 | GnRH secretion | 4.62E-02 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Vardenafil | hsa04932 | Non-alcoholic fatty liver disease | 7.01E-05 | 11 | P01375, P49841, O43521, P48023, O75460, P01584, P13073, P12074, Q16718, O95298, O14521 | TNF, GSK3B, BCL2L11, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA5, NDUFC2, SDHD | More | | Vardenafil | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.72E-02 | 5 | P42224, Q12778, P49767, P17252, P19174 | STAT1, FOXO1, VEGFC, PRKCA, PLCG1 | More | | Vardenafil | hsa04934 | Cushing syndrome | 3.48E-03 | 4 | Q99941, P51828, O15169, Q13557 | CREBL1, ADCY7, AXIN1, CAMK2D | More | | Vardenafil | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Vardenafil | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Vardenafil | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Vardenafil | hsa04970 | Salivary secretion | 4.78E-02 | 3 | Q08828, P51828, P0DP23 | ADCY1, ADCY7, CALM1 | More | | Vardenafil | hsa04971 | Gastric acid secretion | 1.48E-02 | 3 | P51828, P15311, Q13557 | ADCY7, VIL2, CAMK2D | More | | Vardenafil | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Vardenafil | hsa04976 | Bile secretion | 3.14E-03 | 5 | O43315, Q08828, P51828, P08183, Q14032 | AQP9, ADCY1, ADCY7, ABCB1, BAAT | More | | Vardenafil | hsa05010 | Alzheimer disease | 2.07E-02 | 7 | Q92542, P05496, P12074, O75460, P01584, O15169, P45880 | NCSTN, ATP5G1, COX6A1, ERN1, IL1B, AXIN1, VDAC2 | More | | Vardenafil | hsa05012 | Parkinson disease | 3.12E-02 | 6 | Q16718, O14521, P19174, P0DP23, Q13509, P68371 | NDUFA5, SDHD, PLCG1, CALM1, TUBB3, TUBB2C | More | | Vardenafil | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Vardenafil | hsa05017 | Spinocerebellar ataxia | 2.16E-02 | 2 | Q8TB72, P21796 | PUM2, VDAC1 | More | | Vardenafil | hsa05020 | Prion disease | 1.37E-03 | 11 | P01584, P46531, P11142, Q16718, O14521, P05496, P12074, P45880, P49841, Q99941, Q16539 | IL1B, NOTCH1, HSPA8, NDUFA5, SDHD, ATP5G1, COX6A1, VDAC2, GSK3B, CREBL1, MAPK14 | More | | Vardenafil | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.14E-03 | 11 | Q13509, P68371, P49841, Q16718, O14521, Q13561, P19174, P17252, Q16539, Q08752, P0DP23 | TUBB3, TUBB2C, GSK3B, NDUFA5, SDHD, DCTN2, PLCG1, PRKCA, MAPK14, PPID, CALM1 | More | | Vardenafil | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Vardenafil | hsa05110 | Vibrio cholerae infection | 1.98E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Vardenafil | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.96E-04 | 6 | Q16539, P09341, P19875, P19174, P25024, P25025 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Vardenafil | hsa05132 | Salmonella infection | 1.70E-02 | 8 | P25963, P08238, P04406, O75369, Q13561, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, GAPDH, FLNB, DCTN2, TUBB3, TUBB2C, VPS41 | More | | Vardenafil | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Vardenafil | hsa05134 | Legionellosis | 8.80E-04 | 7 | P01584, Q9NR31, P11215, P0DMV8, P11142, P09341, P19875 | IL1B, SAR1A, ITGAM, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Vardenafil | hsa05140 | Leishmaniasis | 2.25E-05 | 10 | O75015, P14598, P42224, P13765, O60603, P25963, P29350, P49006, Q16539, Q15080 | FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Vardenafil | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Vardenafil | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Vardenafil | hsa05146 | Amoebiasis | 5.28E-06 | 10 | P09341, P19875, P14778, P27930, O60603, P42338, P11215, P05089, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TLR2, PIK3CB, ITGAM, ARG1, ACTN1, CTSG | More | | Vardenafil | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Vardenafil | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Vardenafil | hsa05163 | Human cytomegalovirus infection | 2.84E-04 | 15 | P01375, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, P04637, O00463 | TNF, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, TP53, TRAF5 | More | | Vardenafil | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 5.71E-03 | 8 | P01568, P42224, P25963, P40189, P62873, P19174, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, IL6ST, GNB1, PLCG1, CSF2, CALM1 | More | | Vardenafil | hsa05168 | Herpes simplex virus 1 infection | 4.15E-03 | 12 | P25963, P01568, Q9GZY0, P42224, Q07955, Q01130, Q13243, Q13398, Q03923, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, NXF2; NXF2B, STAT1, SFRS1, SFRS2, SFRS5, ZNF211, ZNF85, ZNF140, ZNF189, ZNF212 | More | | Vardenafil | hsa05169 | Epstein-Barr virus infection | 3.72E-02 | 6 | Q13547, P42338, P07948, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, RUNX3, GADD45B, CD3E | More | | Vardenafil | hsa05171 | Coronavirus disease - COVID-19 | 1.36E-02 | 7 | P25963, P42224, P01568, P40189, P04141, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, CSF2, PLCG1, PRKCA | More | | Vardenafil | hsa05200 | Pathways in cancer | 1.67E-03 | 19 | P08238, P42224, P25963, P19174, P17252, P43246, Q13485, P52701, P14923, P30279, P49767, Q12778, P62873, P63218, P78417, O75293, P0DP23, P01568, P40189 | HSP90AB1, STAT1, NFKBIA, PLCG1, PRKCA, MSH2, SMAD4, MSH6, JUP, CCND2, VEGFC, FOXO1, GNB1, GNG5, GSTO1, GADD45B, CALM1, IFNA21, IL6ST | More | | Vardenafil | hsa05202 | Transcriptional misregulation in cancer | 1.45E-02 | 12 | Q15532, P41732, P14780, P27930, P14923, Q16548, Q13077, O15550, P35226, P05164, P08246, P24522 | SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, TRAF1, UTX, BMI1, MPO, ELA2, GADD45A | More | | Vardenafil | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Vardenafil | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Vardenafil | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Vardenafil | hsa05210 | Colorectal cancer | 4.94E-02 | 2 | Q13485, P52701 | SMAD4, MSH6 | More | | Vardenafil | hsa05214 | Glioma | 1.09E-02 | 4 | P0DP23, P17252, P19174, O75293 | CALM1, PRKCA, PLCG1, GADD45B | More | | Vardenafil | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Vardenafil | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Vardenafil | hsa05231 | Choline metabolism in cancer | 2.25E-03 | 5 | Q9NRA1, Q9Y259, P19174, P23743, P17252 | PDGFC, CHKB, PLCG1, DGKA, PRKCA | More | | Vardenafil | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.41E-06 | 15 | P25963, P42338, O95267, P19174, P07766, P20963, P09693, P06239, P29350, P42224, O60603, P10747, Q04759, Q16539, P01730 | NFKBIA, PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PTPN6, STAT1, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Vardenafil | hsa05322 | Systemic lupus erythematosus | 1.49E-05 | 8 | P08311, P09871, Q93077, P62807, Q16778, O60814, P68431, P12814 | CTSG, C1S, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1 | More | | Vardenafil | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Vardenafil | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Vardenafil | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Vardenafil | hsa05415 | Diabetic cardiomyopathy | 5.17E-04 | 8 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B, GAPDH | More | | Vardenafil | hsa05418 | Fluid shear stress and atherosclerosis | 1.26E-04 | 8 | Q16539, Q14145, P10599, P14780, P01375, P04637, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2 | More | | |